SC35 plays a role in T cell development and alternative splicing of CD45 - PubMed (original) (raw)
SC35 plays a role in T cell development and alternative splicing of CD45
H Y Wang et al. Mol Cell. 2001 Feb.
Free article
Abstract
Molecular diversity via alternative splicing is important for cellular function and development. SR proteins are strong candidate regulators of alternative splicing because they can modulate splice site selection. However, endogenous substrates for SR proteins are largely unknown, and their roles as splicing regulators in vertebrate development are unclear. Here we report that Cre-mediated conditional deletion of the prototypical SR protein SC35 in the thymus causes a defect in T cell maturation. Deletion of SC35 alters alternative splicing of CD45, a receptor tyrosine phosphatase known to be regulated by differential splicing during thymocyte development and activation. This study establishes a model to address the function of SR proteins in physiological settings and reveals a critical role of SC35 in a T cell-specific regulated splicing pathway.
Similar articles
- SF2 and SRp55 regulation of CD45 exon 4 skipping during T cell activation.
Lemaire R, Winne A, Sarkissian M, Lafyatis R. Lemaire R, et al. Eur J Immunol. 1999 Mar;29(3):823-37. doi: 10.1002/(SICI)1521-4141(199903)29:03<823::AID-IMMU823>3.0.CO;2-C. Eur J Immunol. 1999. PMID: 10092085 - A study on CD45 isoform expression during T-cell development and selection events in the human thymus.
Fukuhara K, Okumura M, Shiono H, Inoue M, Kadota Y, Miyoshi S, Matsuda H. Fukuhara K, et al. Hum Immunol. 2002 May;63(5):394-404. doi: 10.1016/s0198-8859(02)00379-8. Hum Immunol. 2002. PMID: 11975983 - Regulation of alternative splicing of CD45 by antagonistic effects of SR protein splicing factors.
ten Dam GB, Zilch CF, Wallace D, Wieringa B, Beverley PC, Poels LG, Screaton GR. ten Dam GB, et al. J Immunol. 2000 May 15;164(10):5287-95. doi: 10.4049/jimmunol.164.10.5287. J Immunol. 2000. PMID: 10799890 - Splice factor mutations and alternative splicing as drivers of hematopoietic malignancy.
Hahn CN, Venugopal P, Scott HS, Hiwase DK. Hahn CN, et al. Immunol Rev. 2015 Jan;263(1):257-78. doi: 10.1111/imr.12241. Immunol Rev. 2015. PMID: 25510282 Review. - CD45 (leucocyte common antigen) expression in T and B lymphocyte subsets.
Poppema S, Lai R, Visser L, Yan XJ. Poppema S, et al. Leuk Lymphoma. 1996 Jan;20(3-4):217-22. doi: 10.3109/10428199609051610. Leuk Lymphoma. 1996. PMID: 8624459 Review.
Cited by
- Splicing regulator SC35 is essential for genomic stability and cell proliferation during mammalian organogenesis.
Xiao R, Sun Y, Ding JH, Lin S, Rose DW, Rosenfeld MG, Fu XD, Li X. Xiao R, et al. Mol Cell Biol. 2007 Aug;27(15):5393-402. doi: 10.1128/MCB.00288-07. Epub 2007 May 25. Mol Cell Biol. 2007. PMID: 17526736 Free PMC article. - The impact of alternative splicing in vivo: mouse models show the way.
Möröy T, Heyd F. Möröy T, et al. RNA. 2007 Aug;13(8):1155-71. doi: 10.1261/rna.554607. Epub 2007 Jun 11. RNA. 2007. PMID: 17563071 Free PMC article. Review. - Alternative splicing is frequent during early embryonic development in mouse.
Revil T, Gaffney D, Dias C, Majewski J, Jerome-Majewska LA. Revil T, et al. BMC Genomics. 2010 Jun 23;11:399. doi: 10.1186/1471-2164-11-399. BMC Genomics. 2010. PMID: 20573213 Free PMC article. - SRSF6 balances mitochondrial-driven innate immune outcomes through alternative splicing of BAX.
Wagner AR, Weindel CG, West KO, Scott HM, Watson RO, Patrick KL. Wagner AR, et al. Elife. 2022 Nov 21;11:e82244. doi: 10.7554/eLife.82244. Elife. 2022. PMID: 36409059 Free PMC article. - RNA Regulators in Leukemia and Lymphoma.
Prieto C, Kharas MG. Prieto C, et al. Cold Spring Harb Perspect Med. 2020 May 1;10(5):a034967. doi: 10.1101/cshperspect.a034967. Cold Spring Harb Perspect Med. 2020. PMID: 31615866 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous